Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tau Biomarkers in Late-onset Psychosis (LOP)

NCT06336382 is registered in ClinicalTrials.gov with Jeremy Koppel as lead sponsor.

NCT NCT06336382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06336382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tau Biomarkers in Late-onset Psychosis (LOP)
Lead sponsor
Jeremy Koppel
Phase
Observational
Overall status
Recruiting
Start date
February 16, 2024
Completion date
June 30, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delusional disorder (late onset), late onset schizophrenia